SCHEMBL5506799

SCHEMBL5506799

COc1ccc2ncnc(OCC3CCC(N)CN3CC(=O)OC(C)(C)C)c2c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MTNR1B P49286 6/20 0.41
MTNR1A P48039 4/20 0.41
PIK3CA P42336 5/20 0.40
PIK3CD O00329 4/20 0.40
PIK3CB P42338 3/20 0.40
PIK3CG P48736 3/20 0.40
ENPP1 P22413 1/20 0.38
MAPK7 Q13164 1/20 0.37
KDM4E B2RXH2 1/20 0.35
ERBB2 P04626 1/20 0.35
BRAF P15056 1/20 0.35
KDR P35968 1/20 0.35
MAPK14 Q16539 1/20 0.35
TNNI3K Q59H18 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5511779 0.77 MTNR1B (0.47) MTNR1BMTNR1APIK3CAPIK3CDPIK3CB
SCHEMBL5511774 0.77 MTNR1B (0.47) MTNR1BMTNR1APIK3CAPIK3CDPIK3CB
SCHEMBL5511776 0.77 MTNR1B (0.47) MTNR1BMTNR1APIK3CAPIK3CDPIK3CB
SCHEMBL632999 0.76 PIK3CD (0.51) MTNR1BMTNR1APIK3CAPIK3CDPIK3CB
SCHEMBL3117210 0.73 MTNR1B (0.46) MTNR1BMTNR1AENPP1KDM4EIRAK4
SCHEMBL5507684 0.70 CA1 (0.40) MTNR1BMTNR1APIK3CAPIK3CDPIK3CB
SCHEMBL5503330 0.70 MTNR1B (0.43) MTNR1BMTNR1AENPP1MAPK7KDM4E
SCHEMBL3251044 0.69 MTNR1B (0.53) MTNR1BMTNR1AENPP1KDM4ELMNA
SCHEMBL3251040 0.69 MTNR1B (0.53) MTNR1BMTNR1AENPP1KDM4ELMNA
SCHEMBL632812 0.69 PIK3CD (0.76) MTNR1BPIK3CAPIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799676-A2 NEW BICYCLIC ANTIBIOTICS Actelion Pharmaceuticals Ltd. (CH) 2007-06-27 EP disclosed
WO-2006032466-A2 NEW BICYCLIC ANTIBIOTICS ACTELION PHARMACEUTICALS LTD (CH) 2006-03-30 WO disclosed